NOMURA HOLDINGS INC 13D and 13G filings for Poseida Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:36 pm Sale | 2025-03-31 | 13G | Poseida Therapeutics, Inc. PSTX | NOMURA HOLDINGS INC | 0 0.000% | -5,115,015 (Position Closed) | Filing |
| 2025-02-14 4:54 pm Purchase | 2024-12-31 | 13G | Poseida Therapeutics, Inc. PSTX | NOMURA HOLDINGS INC | 5,115,015 5.200% | 5,115,015 (New Position) | Filing |